1. $ONCY honestly, wait is it going to take to move these thing. R/S is coming or delisting. I ve been long and tired seeing this action

  2. $ONCY other co. s move more on no news than this with good news. pop&drop.

  3. $ONCY excellent Cancer news out today and we are ONLY UP .01

  4. $ONCY i m convinced that someone is purposely keeping our lid on until they have majority of free shares!

  5. $ONCY: New SEC Filing for ONCY: Form 6-K, No. 0001279569-15-001723 http://stocknewsflow.com/1129928_000127956915001723_0001279569-15-001723

  6. Oncolytics: News Release Dated August 27, 2015 http://www.conferencecalltranscripts.org/8/summary/?id=1963446 $ONCY

  7. $ONCY with these positive results buyout is inevitable.. Coming conference should spike interest!

  8. $ONCY AF hates ONCY. Every PR he will tweet a negative. Today he said the PR left out something from the abstract.

  9. $ONCY classic oncy reaction

  10. $ONCY oncy about to get bouncy :) IN .54

  11. $ONCY up 34% PM to just 3% intraday...SMH...

  12. $GBSN my portfolio: $GBSN $ONCY $PTN $BAA

  13. $ONCY holding

  14. The presentation w cover updated results, incl longer-term survival data, from $ONCY s REO 016 Phase 2 study in Non-Small Cell Lung Cancer

  15. $ONCY Will make an oral presentation at intrnt l Assn for the Study of Lung Cancer 16th World Conf on Lung Cancer on Sept 9, 2015.

  16. $ONCY this is just going to start ripping

  17. $ONCY no idea why this isnt going up.

  18. $ONCY Near Tripling of Two-Year Survival Compared to Historical Controls ... but this now my $ino friends

  19. $ONCY results: http://www.prnewswire.com/news-releases/oncolytics-biotech-inc-collaborators-to-present-survival-data-from-reo-016-study-in-non-small-cell-lung-cancer-523061611.html

  20. $ONCY $ONCY nothing to see here folks...just phenomenol stage 4 cancer results

  21. $ONCY im I having a flash back from yesterday?

  22. Premarket Top % Gainers: $NQ 53%, $TBIO 25%, $FORD 25%, $ONTX 20%, $ONCY 13%, $GBSN 13%, $BURL 12%, $CEO 11%, $NADL $RUSL $ADAT $SIG $EXEL

  23. $ONCY Oncolytics Biotech® Inc. to Present Survival Data from REO 016 Study in Non-Small Cell Lung Cancer http://www.barchart.com/headlines/story/63572/oncolytics-biotech-inc-collaborators-to-present-survival-data-from-reo-016-study-in-non-small-cell-lung-cancer?&utm_source=twitter&utm_medium=social-media&utm_campaign=addtoany&utm_source=twitter&utm_medium=social-media&utm_campaign=addtoany

  24. $ONCY Reolysin will become the standard of care with KRAS mutated cancer...these are the worst types of cancers

  25. $ONCY 7 patients remain alive after 34.2 months (26.9-71.5 mon), 2 patients show no evidence of disease progression to date (50 and 37 mon)